[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368554-105":59,"doc-detail-368554-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","risk-factors-and-outcomes-of-clostridioides-difficile-infection-in-patients-with-colorectal-cancer-critical-perspective-in-management","Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer - critical perspective in management","","Colorectal cancer (CRC) ranks among the leading global cancers and poses major health and social burdens. Clostridioides difficile infection (CDI) is a key nosocomial infection, with higher incidence in cancer patients than in non-cancer populations. Mechanisms include gut microbiota dysbiosis, extensive surgery, chemotherapy, prolonged hospitalization, and antimicrobial therapy, which weaken host defenses and increase susceptibility. CDI emergence in CRC patients often drives therapy escalation and longer hospital stays, underscoring the need for effective CDI management. This review discusses CDI risk factors in CRC and summarizes prevention, diagnosis, and treatment approaches aiming to minimize disruption to gut microbiota diversity, improving understanding of CDI-CRC interplay and supporting microbiota balance restoration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-factors-and-outcomes-of-clostridioides-difficile-infection-in-patients-with-colorectal-cancer-critical-perspective-in-management/368554/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-factors-and-outcomes-of-clostridioides-difficile-infection-in-patients-with-colorectal-cancer-critical-perspective-in-management/368554.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is CDI more common in patients with colorectal cancer?","Question",{"text":112,"@type":113},"CRC patients face multiple risk drivers such as gut microbiota dysbiosis, extensive surgery, chemotherapy, prolonged hospitalization, and antimicrobial therapy. These factors compromise host defenses against CDI.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CDI affect CRC patient care?",{"text":117,"@type":113},"The emergence of CDI in CRC patients can require therapy escalation and lead to prolonged hospitalization, increasing clinical and resource burden.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the review’s main focus regarding CDI management in CRC?",{"text":121,"@type":113},"It discusses common CDI risk factors in CRC and summarizes available prevention, detection, and treatment techniques, emphasizing approaches with the lowest impact on gut microbiota diversity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368554,1790621407,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Raeisi et al. Gut Pathogens (2025) 17:44 [https://doi.org/10.1186/s13099-025-00717-0](https://doi.org/10.1186/s13099-025-00717-0)  \nGut Pathogens  \n REVIEW Open Access  \nRisk factors and outcomes of Clostridioides   difficile infection in patients with colorectal cancer: critical perspective in management  \nHamideh Raeisi 1* , Spigaglia Patrizia2, Amir Sadeghi1, Fabrizio Barbanti2, Glenn Tillotson3, Hossein Safarpour4,5, Mohamadreza Zali1 and Ehsan Nazemalhosseini Mojarad6*  \nAbstract  \nColorectal cancer (CRC) ranks as the third most prevalent cancer worldwide, causing a serious threat to global health and social burden. Clostridioides difficile infection (CDI) is one of the most important nosocomial infections and has a higher incidence in cancerous population compared with non-cancerous cases. Different risk factors, including gut microbiota dysbiosis, extensive surgery, chemotherapy, prolonged hospitalization, and antimicrobial therapy, compromise host defenses against CDI and contribute to cancer patients’ susceptibility to this infection. The emergence of CDI in patients with CRC creates conditions for therapy escalation and prolonged hospitalization, highlighting the need for correct and effective CDI management in these patients. Here, common risk factors associated with CDI in patients with CRC are discussed. In addition, different available techniques for the prevention, detection, and treatment of CDI with the lowest impact on gut microbiota diversity are summarized. This review aims to improve the understanding of the interplay between CDI and CRC and provide new insights into restoring and maintaining gut microbiota balance during CDI management in patients with CRC.  \nKeywords Colorectal cancer, Clostridioides difficile infection, Diagnosis, Treatment, Gut microbiota  \n*Correspondence: Hamideh Raeisi[ha.raeesi@gmail.com](ha.raeesi@gmail.com)  \nEhsan Nazemalhosseini Mojarad[e. nazemalhosseini_mojarad@lumc.nl](e. nazemalhosseini_mojarad@lumc.nl)  \n1 Gastroenterology and Liver Diseases Research Centre, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n2 Department of Infectious Diseases, Istituto Superiore di Sanità,  \n00161 Rome, Italy  \n3 GST Micro LLC, North, VA, USA  \n4 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran  \n5 Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran  \n6 Department of Surgery, Leiden University Medical Center, Leiden, Netherlands  \nBackground  \nColorectal cancer (CRC) is the third most prevalent malignancy and the second deadliest, with 1.8 million new cases and 881,000 deaths worldwide in 2018 [1]. Importantly, CRC was identified as the cause of 10% of new cancer cases and cancer-related deaths globally in 2020 [2]. CRC is caused by genetic mutations and epigenetic alterations in colonic cells, leading to the conversion of epithelial cells into adenocarcinomas [2, 3]. In this regard, somatic/acquired or inherited genetic mutations and environmental factors, including dietary food regimes, physical inactivity, and smoking, are risk factors related to the prevalence of CRC [4, 5]. Recently, dysbiotic microbiota has been identified as a key factor in the genesis of cancer progression [6], which is typically marked by a decreased level of beneficial microbes and an increased level of enteric pathogens [7].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted mate","cbCaieeXOEMSi8xB","https://ap.wps.com/l/cbCaieeXOEMSi8xB","pdf",1802892,22,"English","# Background\n## Colorectal cancer and its drivers\n## Conventional CRC treatment and microbiota disruption\n## Gut microbiota changes and infection risk\n# CDI in CRC\n## Dysbiosis as a precursor to CDI\n## CDI burden and clinical implications","[{\"question\":\"Why is CDI more common in patients with colorectal cancer?\",\"answer\":\"CRC patients face multiple risk drivers such as gut microbiota dysbiosis, extensive surgery, chemotherapy, prolonged hospitalization, and antimicrobial therapy. These factors compromise host defenses against CDI.\"},{\"question\":\"How does CDI affect CRC patient care?\",\"answer\":\"The emergence of CDI in CRC patients can require therapy escalation and lead to prolonged hospitalization, increasing clinical and resource burden.\"},{\"question\":\"What is the review’s main focus regarding CDI management in CRC?\",\"answer\":\"It discusses common CDI risk factors in CRC and summarizes available prevention, detection, and treatment techniques, emphasizing approaches with the lowest impact on gut microbiota diversity.\"}]","Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer - critical perspective in management | PDF",1790177475,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b770b3edbcdb4a22e427128aec928ce7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c4b2401dfe859d58f58f969b9467bf9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/caccab87a600592a120bf4667d9496eb.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e51cda1cdada45a9fcbb5147e6d83bf.webp",980,1301]